Meeting
2019 Genitourinary Cancers Symposium
Malignant pheochromocytoma: A comprehensive genomic profiling study.
Authors
Gennady Bratslavsky
SUNY Upstate Medical University, Syracuse, NY
Gennady Bratslavsky , Andrea Necchi , Oleg Shapiro , Joseph Jacob , Laurie M. Gay , Brian Michael Alexander , Julia Andrea Elvin , Jo-Anne Vergilio , Jonathan Keith Killian , Nhu Thi Nho , Shakti Ramkissoon , Eric Allan Severson , Amanda Hemmerich , Siraj Mahamed Ali , Jon Chung , Venkataprasanth P. Reddy , Vincent A. Miller , Alexa Betzig Schrock , Nick Liu , Jeffrey S. Ross
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, Testicular, and Adrenal Cancers
Sub Track
Adrenal Cancer
Citation
J Clin Oncol 37, 2019 (suppl 7S; abstr 508)
DOI
10.1200/JCO.2019.37.7_suppl.508
Abstract #
508
Poster Bd #
B8
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Association between tumor mutational burden (TMB) and mutational profile and its effect on overall survival: A post hoc analysis of patients with TMB-high and TMB-low metastatic cancer treated with immune checkpoint inhibitors (ICI).
First Author: Camila Bragança Xavier
Poster
2024 ASCO Genitourinary Cancers Symposium
Malignant epithelioid angiomyolipoma (eAML)/PEComa of the kidney: A genomic landscape study.
First Author: Rebecca A Sager
Poster
2023 ASCO Annual Meeting
A phase II study of olaparib (AZD2281) in patients (Pts) with metastatic/advanced urothelial carcinoma and other genitourinary (GU) tumors with DNA-repair defects.
First Author: Elias Chandran
Poster
2022 ASCO Annual Meeting
Comprehensive genomic profiling (CGP) of chromophobe renal cell carcinoma (chrRCC) compared with non-chromophobe RCC (nonchrRCC): Impact of FLCN genomic alteration (GA) status.
First Author: Gennady Bratslavsky